๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
SynAct Pharma AB (publ) (STO:SYNACT)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
13.00
-0.12 (-0.91%)
Nov 20, 2026, 5:29 PM CET

SynAct Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-107.67-116.29-89.67-149.84-105.57-76.56
Net Income
-102.63-110.83-82.4-215.81-99.21-69.3
Earnings Per Share
-1.87-2.17-2.08-6.64-3.60-2.68
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
42.3653.4161.2162.4108.2524
Total Debt
45.531.211.880.642.063.09
Net Cash (Debt)
-3.1752.259.3361.76106.1820.91
Net Cash Growth
--12.02%-3.94%-41.84%407.85%43.72%
Net Cash Per Share
-0.061.021.501.903.850.81

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-110.17-97.33-89.2-100.18-117.56-65
Free Cash Flow
-110.17-97.33-89.2-100.18-117.56-65
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.